* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Monday, July 21, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    12 ‘Late Show’ Moments Proving Stephen Colbert Can’t Be Replaced – The Mountaineer

    12 Unforgettable ‘Late Show’ Moments That Prove Stephen Colbert Is Truly One of a Kind

    Canes owner Tom Dundon’s real estate firm eyes entertainment complex near RDU – The Business Journals

    Canes Owner Tom Dundon’s Real Estate Firm Unveils Plans for Thrilling New Entertainment Complex Near RDU

    Inspired Entertainment, Inc.’s (NASDAQ:INSE) Price Is Right But Growth Is Lacking After Shares Rocket 29% – simplywall.st

    Inspired Entertainment Soars 29% but Growth Momentum Falls Short

    Kroger shares summer entertainment tips – Supermarket Perimeter

    Ultimate Summer Entertainment Tips to Make Your Season Unforgettable

    Theater at Santa Fe’s San Isidro Plaza will be converted into IMAX, family entertainment venue – Santa Fe New Mexican

    Santa Fe’s San Isidro Plaza Theater Transforms into Exciting IMAX Family Entertainment Venue

    B&B Theatres will open massive entertainment complex in Texas – The Business Journals

    B&B Theatres will open massive entertainment complex in Texas – The Business Journals

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology

    Defence Holdings PLC Transitions from Esports to Pioneering Defence Technology

    Bull of the Day: Credo Technology Group (CRDO) – Yahoo Finance

    Bull of the Day: Why Credo Technology Group (CRDO) Is Poised for a Breakout

    BlackSky Technology Inc. Stock Analysis and Forecast – Explosive wealth accumulation – Jammu Links News

    BlackSky Technology Inc.: Unlocking Explosive Wealth Potential Through Expert Stock Analysis and Forecast

    Polypurine Hairpin Technology is Safe, Effective at Inhibiting PCSK9 to Regulate Cholesterol – Pharmacy Times

    Polypurine Hairpin Technology: A Safe and Powerful Breakthrough for Controlling Cholesterol by Targeting PCSK9

    A major AI training data set contains millions of examples of personal data – MIT Technology Review

    A major AI training data set contains millions of examples of personal data – MIT Technology Review

    Simpson College to purchase medical simulation technology with grant funds – Iowa Capital Dispatch

    Simpson College to purchase medical simulation technology with grant funds – Iowa Capital Dispatch

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    12 ‘Late Show’ Moments Proving Stephen Colbert Can’t Be Replaced – The Mountaineer

    12 Unforgettable ‘Late Show’ Moments That Prove Stephen Colbert Is Truly One of a Kind

    Canes owner Tom Dundon’s real estate firm eyes entertainment complex near RDU – The Business Journals

    Canes Owner Tom Dundon’s Real Estate Firm Unveils Plans for Thrilling New Entertainment Complex Near RDU

    Inspired Entertainment, Inc.’s (NASDAQ:INSE) Price Is Right But Growth Is Lacking After Shares Rocket 29% – simplywall.st

    Inspired Entertainment Soars 29% but Growth Momentum Falls Short

    Kroger shares summer entertainment tips – Supermarket Perimeter

    Ultimate Summer Entertainment Tips to Make Your Season Unforgettable

    Theater at Santa Fe’s San Isidro Plaza will be converted into IMAX, family entertainment venue – Santa Fe New Mexican

    Santa Fe’s San Isidro Plaza Theater Transforms into Exciting IMAX Family Entertainment Venue

    B&B Theatres will open massive entertainment complex in Texas – The Business Journals

    B&B Theatres will open massive entertainment complex in Texas – The Business Journals

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology

    Defence Holdings PLC Transitions from Esports to Pioneering Defence Technology

    Bull of the Day: Credo Technology Group (CRDO) – Yahoo Finance

    Bull of the Day: Why Credo Technology Group (CRDO) Is Poised for a Breakout

    BlackSky Technology Inc. Stock Analysis and Forecast – Explosive wealth accumulation – Jammu Links News

    BlackSky Technology Inc.: Unlocking Explosive Wealth Potential Through Expert Stock Analysis and Forecast

    Polypurine Hairpin Technology is Safe, Effective at Inhibiting PCSK9 to Regulate Cholesterol – Pharmacy Times

    Polypurine Hairpin Technology: A Safe and Powerful Breakthrough for Controlling Cholesterol by Targeting PCSK9

    A major AI training data set contains millions of examples of personal data – MIT Technology Review

    A major AI training data set contains millions of examples of personal data – MIT Technology Review

    Simpson College to purchase medical simulation technology with grant funds – Iowa Capital Dispatch

    Simpson College to purchase medical simulation technology with grant funds – Iowa Capital Dispatch

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Novel Drug Shows Promise for Hidradenitis Suppurativa

March 11, 2024
in Health
Novel Drug Shows Promise for Hidradenitis Suppurativa
Share on FacebookShare on Twitter

SAN DIEGO — The investigative oral Bruton’s tyrosine kinase (BTK) inhibitor remibrutinib shows promise in patients with moderate to severe hidradenitis suppurativa (HS), results from a randomized 16-week phase 2 trial showed.

“Research shows that the TNF-alpha and IL-17 signaling pathways have important roles in HS,” lead investigator Alexa B. Kimball, MD, MPH, from the Clinical Laboratory for Epidemiology and Applied Research in Skin at Beth Israel Deaconess Medical Center, Boston, said at the annual meeting of the American Academy of Dermatology. “However, several additional pathways are thought to contribute to disease pathogenesis.”

The presence of B cells and plasma cells has been reported in HS lesions, she continued, including early lesions, with BTK activation as a central signal transduction pathway. For the current study, Kimball and colleagues evaluated the safety and efficacy of remibrutinib (LOU064), an oral, highly selective BTK inhibitor, in 77 adults with moderate to severe HS for at least 12 months in 2 or more anatomical areas with 15 or fewer tunnels beneath the skin.

There were slightly more women than men and more than 90% of study participants were White. The novel drug, which is being developed by Novartis, is also under investigation in other immune-mediated inflammatory diseases, including chronic spontaneous urticaria and multiple sclerosis.

Of the 77 patients, 33 were assigned to receive 100 mg remibrutinib twice per day, 33 received a 25 mg twice-daily dose, and 11 patients received placebo twice per day. The primary endpoint was the proportion of patients who achieved a simplified Hidradenitis Suppurativa Clinical Response (HiSCR) at week 16 compared with pooled placebo. A simplified HiSCR response was defined as at least a 50% reduction in total inflammatory abscess and nodule (AN) count, with no increase in draining tunnels relative to baseline.

Kimball, who is also a professor of dermatology at Harvard University, reported that 80.2% of patients overall completed treatment: 87.9% and 78.8% in the remibrutinib 25 mg and 100 mg arms, respectively, and 76% in the pooled placebo arm. The main reason for treatment discontinuation was patient decision (60.9%). Nearly three quarters of patients in the remibrutinib 25 mg twice-daily arm (72.7%) achieved the simplified HiSCR endpoint, compared with 48.5% of those in the remibrutinib 100 mg twice-daily arm, and 34.7% of those in the placebo arm. 

In other exploratory findings, HiSCR, HiSCR 75, and HiSCR 90 rates were higher at week 16 among patients in both remibrutinib treatment arms compared with placebo, and the study drug also was associated with a greater effect on reduction of the AN count and draining tunnels. Specifically, the estimated mean percentage reduction in AN count was 68% in the 25 mg twice-daily arm, compared with reductions of 57% in the 100 mg twice-daily arm and 49.7% in the placebo arm, respectively. Meanwhile, the estimated mean reductions in draining tunnels were 55.6%, 43.6%, and 10.2%, respectively, in the three arms.

The researchers also observed a greater response on the Patient’s Global Assessment of Skin Pain Numeric Rating Scale 30 (NRS30) in patients treated with remibrutinib compared with those on placebo at week 16 (57.1% in the 100 mg twice-daily arm, compared with 44.4% in the 25 mg twice-daily arm, and 30.4% in the placebo arm). 

In terms of safety, adverse events (AEs) were mainly mild or moderate in severity, Kimball said, with no deaths and only one serious AE reported in each treatment arm: one case of acute pancreatitis in the 25 mg twice-daily arm, a testicular abscess in the pooled placebo arm, and a hypertensive crisis in the 100 mg twice-daily arm. Treatment discontinuations because of AEs were uncommon. Infections (primarily upper respiratory infections such as nasopharyngitis) were the most common AEs in all treatment arms.

“BTK inhibition may emerge as a promising therapeutic option in HS,” Kimball concluded. “This is wonderful news for our HS community. We are looking forward to determining what the optimal dosing will be going forward.”

Jennifer L. Hsiao, MD, associate professor of dermatology and director of the HS clinic at the University of Southern California, Los Angeles, who was asked to comment on the study, said there is “a pressing need for more treatments for patients with HS who suffer from the pain and oftentimes life-limiting nature of this condition.” She characterized the study results as “promising,” 

“We will see if phase 3 trials with more balanced demographics across remibrutinib and placebo arms will reproduce these outcomes,” she continued, “It is exciting to see this potential new medication for HS under continued investigation, especially in light of the current gap in oral therapeutic options for the HS patient community.” Hsiao was not involved with the study.

Kimball disclosed numerous conflicts of interest from various pharmaceutical companies, including the receipt of research grants and consulting fees from Novartis. Hsiao disclosed that she is a member of the board of directors for the Hidradenitis Suppurativa Foundation. She has also served as a consultant for AbbVie, Aclaris, Boehringer Ingelheim, Incyte, Novartis, and UCB; as a speaker for AbbVie, Novartis, and UCB; and as an investigator for Amgen, Boehringer Ingelheim, and Incyte.

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : Medscape – https://www.medscape.com/viewarticle/novel-drug-shows-promise-moderate-severe-hidradenitis-2024a10004j5

Tags: healthNovelshows
Previous Post

Saskatchewan’s McEwen will battle for Brier title after beating Alberta’s Bottcher in semifinal

Next Post

Flexibility Advised for Patients With Personality Disorders

Defence Holdings PLC Transitions from Esports to Pioneering Defence Technology

July 21, 2025
Fanatics aided criminal investigation into sports memorabilia dealer. The dealer was later found dead. – The Athletic – The New York Times

Fanatics Helped Crack Sports Memorabilia Case Before Dealer’s Mysterious Death

July 21, 2025
Architecture Students’ Project Selected for Royal Academy Exhibition – Syracuse University News

Syracuse Architecture Students Selected for Prestigious Royal Academy Exhibition

July 21, 2025
Health experts raise alarm over RFK Jr’s ‘war on science’ amid mass firings and budget cuts – The Guardian

Health Experts Sound the Alarm on RFK Jr’s ‘War on Science’ Amid Mass Firings and Budget Cuts

July 21, 2025
Do dogs know who’s kind? Scientists put it to the test—and got a surprise – ScienceDaily

Do dogs know who’s kind? Scientists put it to the test—and got a surprise – ScienceDaily

July 21, 2025
Making these lifestyle changes reduces chronic disease, even if you have a genetic risk – WPBF

Transform Your Health: Simple Lifestyle Changes That Slash Chronic Disease Risk-Even If It Runs in Your Genes

July 21, 2025
Win a VIP trip to Tokyo – worldathletics.org

Win an Exclusive VIP Trip to Tokyo – Enter Now for Your Chance!

July 21, 2025
Under Governor Shapiro, Pennsylvania is a National Leader in Economic Growth, AI Innovation, and Energy – PA Department of Community & Economic Development (.gov)

Under Governor Shapiro, Pennsylvania is a National Leader in Economic Growth, AI Innovation, and Energy – PA Department of Community & Economic Development (.gov)

July 21, 2025
12 ‘Late Show’ Moments Proving Stephen Colbert Can’t Be Replaced – The Mountaineer

12 Unforgettable ‘Late Show’ Moments That Prove Stephen Colbert Is Truly One of a Kind

July 21, 2025
AI in health care could save lives and money — but not yet – PBS

AI in health care could save lives and money — but not yet – PBS

July 21, 2025

Categories

Archives

July 2025
MTWTFSS
 123456
78910111213
14151617181920
21222324252627
28293031 
« Jun    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (731)
  • Economy (754)
  • Entertainment (21,639)
  • General (16,014)
  • Health (9,792)
  • Lifestyle (762)
  • News (22,149)
  • People (756)
  • Politics (763)
  • Science (15,971)
  • Sports (21,252)
  • Technology (15,737)
  • World (737)

Recent News

Defence Holdings PLC Transitions from Esports to Pioneering Defence Technology

July 21, 2025
Fanatics aided criminal investigation into sports memorabilia dealer. The dealer was later found dead. – The Athletic – The New York Times

Fanatics Helped Crack Sports Memorabilia Case Before Dealer’s Mysterious Death

July 21, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version